Skip to main content
SpringerLink
Log in

Extracellular Matrix: Immunity and Inflammation

  • Chapter
  • First Online:
Extracellular Matrix for Tissue Engineering and Biomaterials

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

Abstract

The extracellular matrix (ECM) is the non-cellular component of any tissues and organs. It provides not only support, tensile strength, and scaffolding for tissues and cells , but also biochemical signals and specialized proteins. The destabilization or alteration of the ECM structural and chemical composition affects growth, morphogenesis , differentiation , migration, communication, survival of all cells as well as inflammation and immune response. Inflammation is a complex defense mechanism characterized by leukocyte migration from the vasculature to control tissue damage induced by pathogenic (bacterial or viral), traumatic, or toxic injury with subsequent deposition of extracellular matrix resulting in tissue repair. At sites of injury, phagocytic cells , namely macrophages and neutrophils, provide innate cell-mediated immunity , and immune cells are influenced in their migration by the topography and composition of the matrix architecture. The physical and biochemical ECM properties are also able to modulate a number of processes in immune cells , especially lymphocytes that can ultimately lead to inefficient immune response. Among the large number of molecules responsible for ECM homeostasis, matrix metalloproteinases, versican , hyaluronan , and thrombospondins are the most involved in inflammation and immunity .

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Adair-Kirk TL, Senior RM. Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol. 2008;40:1101–10.

    Article  CAS  PubMed  Google Scholar 

  2. Adams JC, Lawler J. The thrombospondins. Cold Spring Harb Perspect Biol. 2011;3(10):a009712.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Agarwal SK. Integrins and cadherins as therapeutic targets in fibrosis. Front Pharmacol. 2014;5:131.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Alvarez MJ, Prada F, Salvatierra E, et al. Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. Cancer Res. 2005;65:5123–32.

    Article  CAS  PubMed  Google Scholar 

  5. Amălinei C, Căruntu ID, Giuşcă SE, et al. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol. 2010;51:215–28.

    PubMed  Google Scholar 

  6. Arroyo AG, Iruela-Arispe ML. Extracellular matrix, inhflammation, and the angiogenic response. Cardiovasc Res. 2010;86:226–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001;21:7724–32.

    Article  CAS  PubMed  Google Scholar 

  8. Aspberg A, Binkert C, Ruoslahti E. The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc Natl Acad Sci U S A. 1995;92:10590–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Aspberg A, Adam S, Kostka G, et al. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem. 1999;274:20444–9.

    Article  CAS  PubMed  Google Scholar 

  10. Balbín M, Fueyo A, Tester AM, et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet. 2003;35:252–7.

    Article  PubMed  CAS  Google Scholar 

  11. Berdiaki A, Zafiropoulos A, Fthenou E, et al. Regulation of hyaluronan and versican deposition by growth factors in fibrosarcoma cell lines. Biochim Biophys Acta. 2008;1780:194–202.

    Article  CAS  PubMed  Google Scholar 

  12. Bollyky PL, Wu RP, Falk BA, et al. ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc Natl Acad Sci U S A. 2011;108:7938–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11:529–43.

    Article  CAS  PubMed  Google Scholar 

  14. Butler GS, Overall CM. Matrix metalloproteinase processing of signaling molecules to regulate inflammation. Periodontol. 2000;63:123–48.

    Article  Google Scholar 

  15. Chong HC, Tan CK, Huang RL, et al. Matricellular proteins: a sticky affair with cancers. J Oncol. 2012;2012:351089.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Clark IM, Swingler TE, Sampieri CL, et al. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol. 2008;40:1362–78.

    Article  CAS  PubMed  Google Scholar 

  17. Clark RAF, Henson PM. The molecular and cellular biology of wound repair. New York: Plenum Press; 1988.

    Book  Google Scholar 

  18. Clause KC, Barker TH. Extracellular matrix signaling in morphogenesis and repair. Curr Opin Biotechnol. 2013;24:830–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Day AJ, Prestwich GD. Hyaluronan-binding proteins: tying up the giant. J Biol Chem. 2002;277:4585–8.

    Article  CAS  PubMed  Google Scholar 

  20. Day AJ, Sheehan JK. Hyaluronan: polysaccharide chaos to protein organization. Curr Opin Struct Biol. 2001;11:617–22.

    Article  CAS  PubMed  Google Scholar 

  21. Del Principe D, Lista P, Malorni W, et al. Fibroblast autophagy in fibrotic disorders. J Pathol. 2013;229:208–20.

    Article  PubMed  CAS  Google Scholar 

  22. Denis MC, Mahmood U, Benoist C, et al. Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci U S A. 2004;101:12634–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science. 2009;324:1673–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Dubois B, Masure S, Hurtenbach U, et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest. 1999;104:1507–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ducharme A, Frantz S, Aikawa M, et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000;106:55–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. DuFort CC, Paszek MJ, Weaver VM. Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol. 2011;12:308–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Edelstam GA, Laurent UB, Lundkvist OE, et al. Concentration and turnover of intraperitoneal hyaluronan during inflammation. Inflammation. 1992;16:459–69.

    Article  CAS  PubMed  Google Scholar 

  28. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161–74.

    Article  CAS  PubMed  Google Scholar 

  29. Evanko SP, Tammi MI, Tammi RH, et al. Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev. 2007;59:1351–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123:4195–200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Frey H, Schroeder N, Manon-Jensen T, et al. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J. 2013;280:2165–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Gabison EE, Huet E, Baudouin C, et al. Direct epithelial-stromal interaction in corneal wound healing: role of EMMPRIN/CD147 in MMPs induction and beyond. Prog Retin Eye Res. 2009;28:19–33.

    Article  CAS  PubMed  Google Scholar 

  33. Gaudet AD, Popovich PG. Extracellular matrix regulation of inflammation in the healthy and injured spinal cord. Exp Neurol. 2014;258:24–34.

    Article  CAS  PubMed  Google Scholar 

  34. Gill S, Wight TN, Frevert CW, et al. Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat Rec (Hoboken). 2010;293:968–81.

    Article  CAS  Google Scholar 

  35. Gomis-Rüth FX. Structural aspects of the metzincin clan of metalloendopeptidases. Mol Biotechnol. 2003;24:157–202.

    Article  PubMed  Google Scholar 

  36. Graesser D, Mahooti S, Madri JA. Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis. J Neuroimmunol. 2000;109:21–131.

    Article  Google Scholar 

  37. Grimbert P, Bouguermouh S, Baba N, et al. Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells-from human CD4+ CD25− T cells in response to inflammation. J Immunol. 2006;177:3534–41.

    Article  CAS  PubMed  Google Scholar 

  38. Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A. 1962;48:1014–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Hadler-Olsen E, Fadnes B, Sylte I, et al. Regulation of matrix metalloproteinase activity in health and disease. FEBS J. 2011;278:28–45.

    Article  CAS  PubMed  Google Scholar 

  40. Hay ED. Cell biology of extracellular matrix. New York: Plenum Press; 1991.

    Book  Google Scholar 

  41. Hernandez-Barrantes S, Bernardo M, Toth M, et al. Regulation of membrane type-matrix metalloproteinases. Semin Cancer Biol. 2002;12:131–8.

    Article  CAS  PubMed  Google Scholar 

  42. Hirose J, Kawashima H, Yoshie O, et al. Versican interacts with chemokines and modulates cellular responses. J BiolChem. 2001;276:5228–34.

    CAS  Google Scholar 

  43. Holmbeck K, Bianco P, Caterina J, et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 1999;99:81–92.

    Article  CAS  PubMed  Google Scholar 

  44. Huang H, Campbell SC, Bedford DF, et al. Peroxisome proliferator-activated receptor γ ligands improve the antitumor efficacy of thrombospondin peptide ABT510. Mol Cancer Res. 2004;2:541–50.

    CAS  PubMed  Google Scholar 

  45. Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009;326:1216–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Hynes RO, Yamada KM. Extracellular matrix biology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2012.

    Google Scholar 

  47. Isenberg JS, Frazier WA, Roberts DD. Thrombospondin-1: a physiological regulator of nitric oxide signaling. Cell Mol Life Sci. 2008;65:728–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Isenberg JS, Martin-Manso G, Maxhimer JB, et al. Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer. 2009;9:182–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Isogai Z, Aspberg A, Keene DR, et al. Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J Biol Chem. 2002;277:4565–72.

    Article  CAS  PubMed  Google Scholar 

  50. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol. 2007;23:435–61.

    Article  CAS  PubMed  Google Scholar 

  51. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91:221–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Joronen KR, Ala-aho ML, Majuri H, et al. Adenovirus mediated intra-articular expression of collagenase-3 (MMP-13) induces inflammatory arthritis in mice. Ann Rheum Dis. 2004;63:656–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Joronen K, Kähäri VM, Vuorio E. Temporospatial expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in mouse antigen induced arthritis. Histochem Cell Biol. 2005;124:535–45.

    Article  CAS  PubMed  Google Scholar 

  54. Karamanos N. Extracellular matrix: pathobiology and signaling. Berlin, Boston: Walter de Gruyter; 2012.

    Book  Google Scholar 

  55. Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:123.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol. 2013;13:649–65.

    Article  CAS  PubMed  Google Scholar 

  58. Kieseier BC, Kiefer R, Clements JM, et al. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain. 1998;121:159–66.

    Article  PubMed  Google Scholar 

  59. Kim KH, Burkhart K, Chen P, et al. Tissue inhibitor of metalloproteinase–1 deficiency amplifies acute lung injury in bleomycin-exposed mice. Am J Respir Cell Mol Biol. 2005;33:271–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Kirk JA, Cingolani OH. Thrombospondins in the transition from myocardial infarction to heart failure. J Mol Cell Cardiol. 2016;90:102–10.

    Article  CAS  PubMed  Google Scholar 

  61. Kudo-Saito C, Shirako H, Takeuchi T, et al. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell. 2009;15:195–206.

    Article  CAS  PubMed  Google Scholar 

  62. Kuznetsova SA, Issa P, Perruccio EM, et al. Versican-thrombospondin-1 binding in vitro and colocalization in microfibrils induced by inflammation on vascular smooth muscle cells. J Cell Sci. 2006;119:4499–509.

    Article  CAS  PubMed  Google Scholar 

  63. Laurent TC, Fraser JR. Hyaluronan. FASEB. 1992;J6:2397–404.

    Article  Google Scholar 

  64. LeBaron RG, Zimmermann DR, Ruoslahti E. Hyaluronate binding properties of versican. J Biol Chem. 1992;267:10003–10.

    CAS  PubMed  Google Scholar 

  65. Lelongt B, Bengatta S, Delauche M, et al. Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J Exp Med. 2001;193:793–802.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Lee MM, Yoon BJ, Osiewicz K, et al. Tissue inhibitor of metalloproteinase 1 regulates resistance to infection. Infect Immun. 2005;73:661–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Lee-Sayer SS, Dong Y, Arif AA, et al. The where, when, how, and why of hyaluronan binding by immune cells. Front Immunol. 2015;6:150.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Li L, Li H. Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors. Cancer Biol Ther. 2013;14:796–805.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Li Q, Park PW, Wilson CL, et al. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell. 2002;111:635–46.

    Article  CAS  PubMed  Google Scholar 

  70. Lisi S, D’Amore M, Sisto M. ADAM17 at the interface between inflammation and autoimmunity. Immunol Lett. 2014;S0165-2478(14):00178-3.

    Google Scholar 

  71. Löffek S, Schilling O, Franzke CW. Series “matrix metalloproteinases in lung health and disease”: Biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2011;38:191–208.

    Article  PubMed  CAS  Google Scholar 

  72. Lopez-Dee Z, Pidcock K, Gutierrez LS. Thrombospondin-1: multiple paths to inflammation. Mediat Inflamm. 2011;2011:296069.

    Article  CAS  Google Scholar 

  73. Lu P, Takai K, Weaver VM, et al. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011;3(ii):a005058.

    PubMed  PubMed Central  Google Scholar 

  74. Lundell A, Olin AI, Morgelin M, et al. Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Struct (Camb). 2004;12:1495–506.

    Article  CAS  Google Scholar 

  75. Macri L, Silverstein D, Clark RA. Growth factor binding to the pericellularmatrix and its importance in tissue engineering. Adv Drug Deliv Rev. 2007;59:1366–81.

    Article  CAS  PubMed  Google Scholar 

  76. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991–1045.

    Article  CAS  PubMed  Google Scholar 

  77. McDonald JA, Camenisch TD. Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj J. 2002;1:331–9.

    Article  Google Scholar 

  78. Mecham RP. The extracellular matrix: an overview. Berlin: Springer; 2011.

    Book  Google Scholar 

  79. Mittal R, Gonzalez-Gomez I, Prasadarao NV. Escherichia coli K1 promotes the ligation of CD47 with thrombospondin-1 to prevent the maturation of dendritic cells in the pathogenesis of neonatal meningitis. J Immunol. 2010;185:2998–3006.

    Article  CAS  PubMed  Google Scholar 

  80. Moncada-Pazos A, Obaya AJ, Llamazares M, et al. ADAMTS-12 metalloprotease is necessary for normal inflammatory response. J Biol Chem. 2012;287:39554–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Morris DG, Huang X, Kaminski N, et al. Loss of integrin αvβ6-mediated TGF-β activation causes MMP12-dependent emphysema. Nature. 2003;422:169–73.

    Article  CAS  PubMed  Google Scholar 

  82. Morwood SR, Nicholson LB. Modulation of the immune response by extracellular matrix proteins. Arch Immunol Ther Exp (Warsz). 2006;54:367–74.

    Article  CAS  Google Scholar 

  83. Murasawa Y, Watanabe K, Yoneda M, et al. Homotypic versican G1 domain interactions enhance hyaluronan incorporation into fibrillin microfibrils. J Biol Chem. 2013;288:29170–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562–73.

    Article  CAS  PubMed  Google Scholar 

  85. Newton K, Dixit VM. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol. 2012;4:a006049.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  86. Nissinen L, Kähäri VM. Matrix metalloproteinases in inflammation. Biochim Biophys Acta. 2014;1840:2571–80.

    Article  CAS  PubMed  Google Scholar 

  87. Nygårdas PT, Hinkkanen AE. Up-regulation ofMMP-8 andMMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2002;128:245–54.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Olin AI, Morgelin M, Sasaki T, et al. The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem. 2001;276:1253–61.

    Article  CAS  PubMed  Google Scholar 

  89. Owen CA, Hu Z, Lopez-Otin C, et al. Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J Immunol. 2004;172:7791–803.

    Article  CAS  PubMed  Google Scholar 

  90. Parekh K, Ramachandran S, Cooper J, et al. Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes. Lung Cancer. 2005;47:17–29.

    Article  PubMed  Google Scholar 

  91. Parks WC, Wilson CW, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004;4:617–29.

    Article  CAS  PubMed  Google Scholar 

  92. Peranzoni E, Rivas-Caicedo A, Bougherara H, et al. Positive and negative influence of the matrix architecture on antitumor immune surveillance. Cell Mol Life Sci. 2013;70:4431–48.

    Article  CAS  PubMed  Google Scholar 

  93. Petrey AC, de la Motte CA. Hyaluronan, a crucial regulator of inflammation. Front Immunol. 2014;5:101.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  94. Piperi C, Papavassiliou AG. Molecular mechanisms regulating matrix metalloproteinases. Curr Top Med Chem. 2012;12:1095–112.

    Article  CAS  PubMed  Google Scholar 

  95. Ra HJ, Parks WC. Control of matrix metalloproteinase catalytic activity. Matrix Biol. 2007;26:587–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Reinhardt DP, Sasaki T, Dzamba BJ, et al. Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. J Biol Chem. 1996;271:19489–96.

    Article  CAS  PubMed  Google Scholar 

  97. Rietz A, Spiers J. The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases. Br J Pharmacol. 2012;166:1225–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Sangaletti S, Colombo MP. Matricellular proteins at the crossroad of inflammation and cancer. Cancer Lett. 2008;267:245–53.

    Article  CAS  PubMed  Google Scholar 

  99. Sangaletti S, Stoppacciaro A, Guiducci C, et al. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J Exp Med. 2003;198:1475–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Silini A, Parolini O, Huppertz B, et al. Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies. Curr Stem Cell Res Ther. 2013;8:6–14.

    Article  CAS  PubMed  Google Scholar 

  101. Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol. 2010;10:712–23.

    Article  CAS  PubMed  Google Scholar 

  102. Stenina-Adognravi O. Thrombospondins: old players, new games. Curr Opin Lipidol. 2013;24:401–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006;85:699–715.

    Article  CAS  PubMed  Google Scholar 

  104. Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev. 2006;106:818–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463–516.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Striz I, Brabcova E, Kolesar L, et al. Cytokine networking of innate immunity cells: a potential target of therapy. Clin Sci (Lond). 2014;126:593–612.

    Article  CAS  Google Scholar 

  107. Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci U S A. 1998;95:13221–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Tezvergil-Mutluay A, Agee KA, Hoshika T, et al. The requirement of zinc and calcium ions for functional MMP activity in demineralized dentin matrices. Dent Mater. 2010;26:1059–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Toba H, Cannon PL, Yabluchanskiy A, et al. Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis. Am J Physiol Heart Circ Physiol. 2017;312:H375–83.

    Article  PubMed  Google Scholar 

  110. Uhlin-Hansen L, Wik T, Kjellen L, et al. Proteoglycan metabolism in normal and inflammatory human macrophages. Blood. 1993;82:2880–9.

    CAS  PubMed  Google Scholar 

  111. Van den Steen PE, Opdenakker G, Wormald MR, et al. Matrix remodelling enzymes, the protease cascade and glycosylation. Biochim Biophys Acta. 2001;1528:61–73.

    Article  PubMed  Google Scholar 

  112. Vandenbroucke RE, Dejonckheere E, Van Hauwermeiren F, et al. Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF. EMBO Mol Med. 2013;5:932–48.

    Article  CAS  PubMed Central  Google Scholar 

  113. Vargová V, Pytliak M, Mechírová V. Matrix metalloproteinases. EXS. 2012;103:1–33.

    PubMed  Google Scholar 

  114. Verma S, Kesh K, Ganguly N, et al. Matrix metalloproteinases and gastrointestinal cancers: impacts of dietary antioxidants. J Biol Chem. 2014;5:355–76.

    Google Scholar 

  115. Vermaelen KY, Cataldo D, Tournoy K, et al. Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma. J Immunol. 2003;171:1016–22.

    Article  CAS  PubMed  Google Scholar 

  116. Vigetti D, Karousou E, Viola M, et al. Hyaluronan: biosynthesis and signaling. Biochim Biophys Acta. 2014;1840:2452–9.

    Article  CAS  PubMed  Google Scholar 

  117. Vigetti D, Rizzi M, Moretto P, et al. Glycosaminoglycans and glucose prevent apoptosis in 4-methylumbelliferone-treated human aortic smooth muscle cells. J Biol Chem. 2011;286:34497–503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Vigetti D, Genasetti A, Karousou E, et al. Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion in human endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-kappaB (NF-kappaB) pathway. J Biol Chem. 2011;285:24639–45.

    Article  CAS  Google Scholar 

  119. Vigetti D, Rizzi M, Viola M, et al. The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells. Glycobiology. 2009;19:537–46.

    Article  CAS  PubMed  Google Scholar 

  120. Vincenti MP. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol. 2001;151:121–48.

    CAS  PubMed  Google Scholar 

  121. Volk SW, Iqbal SA, Bayat A. Interactions of the extracellular matrix and progenitor cells in cutaneous wound healing. Adv Wound Care (New Rochelle). 2013;2:261–72.

    Article  Google Scholar 

  122. Wang M, Qin X, Mudgett JS, et al. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci U S A. 1999;96:6885–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Wang Y, Herrera AH, Li Y, et al. Regulation of mature ADAM17 by redox agents for l-selectin shedding. J Immunol. 2009;182:2449–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Wang W, Xu GL, Jia WD, et al. Ligation of TLR2 by versican: a link between inflammation and metastasis. Arch Med Res. 2009;40:321–3.

    Article  PubMed  CAS  Google Scholar 

  125. Werfel J, Krause S, Bischof AG, et al. How changes in extracellular matrix mechanics and gene expression variability might combine to drive cancer progression. PLoS ONE. 2013;8:e76122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Wight TN. The pathobiology of versican. In: Karamanos N, editor. Extracellular matrix: pathobiology and signaling. KG, Berlin: Walter De Gruyter GMBH & Co.; 2012. p. 154–70.

    Google Scholar 

  127. Wight TN, Frevert CW, Debley JS, et al. Interplay of extracellular matrix and leukocytes in lung inflammation. Cell Immunol. 2017;312:1–14.

    Article  CAS  PubMed  Google Scholar 

  128. Wight TN, Kang I, Merrilees MJ. Versican and the control of inflammation. Matrix Biol. 2014;35:152–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Wight TN, Kinsella MG, Evanko SP, et al. Versican and the regulation of cell phenotype in disease. Biochim Biophys Acta. 2014;1840:2441–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  130. Wight TN, Potter-Perigo S. The extracellular matrix: an active or passive player in fibrosis. Am J Physio Gastrointest Liver Physiol. 2011;301:G950–5.

    Article  CAS  Google Scholar 

  131. Wolf K, Alexander S, Schacht V, et al. Collagen based cell migration models in vitro and in vivo. Semin Cell Dev Biol. 2009;20:931–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol. 2004;4:583–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Wu YJ, La Pierre DP, Wu J, et al. The interaction of versican with its binding partners. Cell Res. 2005;15:483–94.

    Article  CAS  PubMed  Google Scholar 

  134. Xiao Q, Ge G. Lysyl oxidase, extracellular matrix remodeling and cancer metastasis. Cancer Microenviron. 2012;5:261–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Yan C, Boyd DD. Regulation of matrix metalloproteinase gene expression. J Cell Physiol. 2007;211:19–26.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University G. d’Annunzio, Chieti-Pescara, Italy

    Amelia Cataldi & Viviana di Giacomo

Authors
  1. Amelia Cataldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Viviana di Giacomo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Viviana di Giacomo .

Editor information

Editors and Affiliations

  1. Department of Hematology, Transfusional Medicine and Biotechnology, Spirito Santo Hospital, Pescara, Italy

    Anna C. Berardi

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cataldi, A., di Giacomo, V. (2018). Extracellular Matrix: Immunity and Inflammation. In: Berardi, A. (eds) Extracellular Matrix for Tissue Engineering and Biomaterials. Stem Cell Biology and Regenerative Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-77023-9_4

Download citation

Publish with us

Policies and ethics

Search

Navigation